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In this review, we discuss how protozoan parasites alter immature and mature B cell compartment. B1 and marginal zone (MZ)
B cells, considered innate like B cells, are activated during protozoan parasite infections, and they generate short lived plasma
cells providing a prompt antibody source. In addition, protozoan infections induce massive B cell response with polyclonal
activation that leads to hypergammaglobulnemia with serum antibodies speciﬁc for the parasites and self and/or non related
antigens. To protect themselves, the parasites have evolved unique ways to evade B cell immune responses inducing apoptosis of
MZ and conventional mature B cells. As a consequence of the parasite induced-apoptosis, the early IgM response and an already
establish humoral immunity are aﬀected during the protozoan parasite infection. Moreover, some trypanosomatides trigger bone
marrow immature B cell apoptosis, inﬂuencing the generation of new mature B cells. Simultaneously with their ability to release
antibodies, B cells produce cytokines/quemokines that inﬂuence the characteristic of cellular immune response and consequently
the progression of parasite infections.
1.BCellsCanPlayProtectiveandPathogenic
Roles inProtozoanInfections
Host resistance in protozoan infections is dependent on both
innate and acquired cell-mediated immune responses. In
addition, several studies have implicated B cells and antibod-
ies (Abs) in host survival and protozoan parasite clearance
[1–3]. B cells can function as Ab-producing cells but they
can also modulate immune responses through critical Ab-
independent mechanisms that include secretion of cytokines
and chemokines as well as antigen presentation [4–6]. Fur-
thermore, B cells can directly modulate dendritic cells and T-
cell subsets, and, consequently, they can inﬂuence adaptive
immunity and the progression of the infection [7]. Accord-
ingly, in protozoan infections B cells may play a protective
and a pathological role. In malaria and trypanosome infec-
tions, Abs appear to play a famajor role in immunity. In
Trypanosoma cruzi and T. brucei gambiense infections, Ab-
dependent cytotoxic reactions against the parasite have been
reported [8]. Several studies demonstrated that Abs are re-
sponsible for the survival of susceptible animals in the initial
phase of T. cruzi infection and for the maintenance of low
levels of parasitemia in the chronic phase [9, 10]. Although
Abs were shown to be responsible for clearing the African
trypanosomes from the blood of infected animals, recent
evidence suggests that the survival time of infected mice does
not necessarily correlate with the ability of the animal to
produce trypanosome-speciﬁc antibody. In general, the
parasite-speciﬁc immune response mounted during proto-
zoan infections is insuﬃcient to completely eradicate the
pathogen, allowing chronic infection.
B cells do not only play protective roles in protozoan
infections. In fact, they are required for the development of
Th2 cell response and, consequently, for the susceptibility to
infection with Leishmania major [11]. BALB/c uMT mice in-
fected with L. major LV39 mount a Th1 response and
present restricted lesion development and contained parasite
replication. Adoptive transfer of B cells from BALB/c mice in2 Journal of Parasitology Research
B-cell-deﬁcient BALB/c uMT mice before infection restores
susceptibility to L. major LV39 and Th2 cell development in
resistant mice.
2.B-Cell Development
Given the role for B cells in conditioning the progression
of protozoan infections, it is important to understand the
kinetics and regulation of the whole B-cell cycle from the
development to the diﬀerentiation into mature and memory
B cells and plasma cells. The humoral immune response has
been shown to be two branched providing an innate-like
response (involving B1 and marginal zone (MZ) B cells) and
an adaptive immune response (involving conventional B2
cells). In the adult, B cells are generated in the bone marrow
(BM) and migrate to the periphery at the transitional B-cell
stage, when they are still short lived and functionally imma-
ture [12, 13]. Conventional B2-cell development occurs via
a series of BM stromal cell-facilitated processes that begin
within the hematopoietic stem cell pool and proceed in hier-
archical steps of lineage commitment [14]. B lymphopoiesis
yields several developmental stages of pre-pro-B, pro-B, pre-
B, and, eventually, immature B cells, which show a high
expression of the IgM form of the antigen receptor and low
or no expression of the IgD maturation marker. To complete
their development, immature B cells migrate through the
periphery;however,only10%reachthespleenastransitional
B cells of the T1 type [15]. In the spleen, transitional B cells
develop into conventional and MZ B cells [16]. B1 cells are
eﬃcientlygeneratedinfetallifeandduringtheﬁrstfewweeks
afterbirth.ThefetalliverisaneﬃcientsourceofB1cells[17];
however, it is not the only one as a recent study identiﬁed a
B1-cell precursor in adult BM [18]. Interestingly, protozoan
parasite infections can aﬀect the diﬀerent compartments of
B-cell development (summarized in Figure 1), inﬂuencing
the generation of new mature B cells or their survival and,
consequently, the cellular immune response.
3.ProtozoanParasiteInfectionsAffect BM
B-Cell Development
BM is the main hematopoietic organ of an adult organism
and is able to provide cells of immune systems rapidly in
cases of infection. Immature B-cell reduction in BM during
an infection would limit the Ab source cells and favour par-
asite replication and chronicity, so the identiﬁcation of the
mechanisms ruling B-cell depletion represents an important
challenge in biomedical research.
WehavereportedthatT.cruziinfectioninducesamarked
loss of immature B cells in the BM and also compromises
recently emigrated B cells in the periphery [19]. The de-
pletion of immature BM B cells was associated with an in-
creased rate of apoptosis, and we established that T. cruzi
trypomastigotes failed to directly induce immature B-cell
apoptosis. We proved that this cell death process occurs in a
Fas/FasL-independent fashion but depends on the presence
of CD11b+ myeloid cells that secrete a product of the
cyclooxygenase pathway that depletes immature B cells [19].
In addition, BM is compromised in other protozoan
parasite infections. In fact, infections with Neospora caninum
[20]a n dT. brucei [21]a l s oc a u s eag e n e r a ld e c r e a s ei nB M
cells. Recently, the T. brucei infection upshot on B lympho-
poiesis has been examined using a C57BL/6 mouse T. brucei
AnTat 1.1E infection model [22]. Using this model, Bockstal
et al. [23] observed that the number of hematopoietic stem
cells was minimally aﬀected, but BM B lymphopoiesis was
severely aﬀected in T. brucei-infected mice, starting with
the common lymphoid progenitor fraction. The pre-pro-
B-cell population showed a 50% reduction by day 20 after
infection, while the subsequent B-cell maturation stage,
that is, the pro-B, pre-B, and immature B-cell populations
reached more than 95% depletion by day 10 after infec-
tion and failed to recover throughout the further course
of infection. In T. brucei infection, mice do not present
increased apoptosis of BM B-cell precursors nor alteration in
the expression of B-cell-development-speciﬁc transcription
factors like Icaros, PU.1, EBF and E2A and the IL-7.
However, T. brucei-infected mice show a reduction in BM
CXCL12 levels [23], indicating that during early T. brucei
infections, B-cell precursors prematurely migrate out of the
BM as a result of the initiation of inﬂammation. Similarly,
CXCL12 decreased production by BM cells was determined
in Plasmodium chabaudi infection [24]. Furthermore, the
signiﬁcant reduction in CXCL12 expression in the BM of 10
days P. chaubaudi-infected mice correlates with a reduction
in B-cell precursor cells. At days 20 and 30 of infection, a
signiﬁcant recovery in CXCL12 expression in BM is detected,
coinciding with a slow recovery of B lymphopoiesis.
4.B1 andMZ B-CellResponse inProtozoan
Parasite Infections
Among the mature B cells, MZ and B1 B cells appear to be
evolutionarily selected and maintained to facilitate prompt
Ab responses. Due to this, they provide a bridge between the
innate and the adaptive arms of the antipathogen immune
response. B1 cells, distinguished from B2 cells by their phe-
notype (B220low CD5+/− CD11b+) and anatomic location
and functional properties, are the dominant population of
B cells in the pleural and peritoneal cavities, but represent
only a small fraction of splenic B cells [25]. B1 cells produce
most of the natural serum IgM and much of the gut IgA and
express a BCR repertoire that is enriched for highly polyspe-
c i ﬁ cr e c e p t o r swi t hl o wa ﬃnities to a broad range of antigens
[26]. Despite the fact that B1 cells are very eﬃcient in the
control of bacterial and viral infections, they apparently do
not play a role in the control of protozoan parasite rep-
lication. Indeed, BALB/c Xid mice carrying an X-linked
mutation (that prevents B1 cell development) infected with
T. cruzi display poor B-cell responses to the infection,
accompanied by low levels of speciﬁc and nonspeciﬁc im-
munoglobulins in the serum [27]. Surprisingly, Xid mice
infected with T. cruzi were able to control parasitemia and
did not show the wasting syndrome observed in wild-type
mice. In addition, they developed almost no pathology early
in the chronic phase. The resistance of these mice to exper-
imental Chagas disease was associated with the absence ofJournal of Parasitology Research 3
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Figure 1: Protozoan parasites aﬀect the diﬀerent B-cell compartments. MZ: marginal zone B cells, GCs: germinal centers.
IL-10-secreting B1 cells and high levels of IFN-gamma [28].
These results suggested that B1 cells play a pathological
ratherthanprotectiveroleinChagas’disease.Additionally,in
T. cruzi infection, we observed a disappearance of peritoneal
B1 cells, due to an enhanced diﬀerentiation into a particular
type of plasma cells, the “Mott-like cells” [29]. Nevertheless,
the speciﬁc role of these cells in the experimental Chagas
disease has not been elucidated yet; their association with
autoimmune manifestations in CD22-deﬁcient mice [30]
andlupus[31,32]suggeststhatthesecellsmaybeinvolvedin
the autoimmune responses observed in T. cruzi infection. We
and others have reported that the peritoneal B-cell response
observed in T. cruzi infection is almost not speciﬁc for the
invading pathogen [29, 33]. However, these “sticky” anti-
bodies could unspeciﬁcally bind to parasites providing pro-
tection.
B1 cells are not only implicated on Ab secretion; in fact,
they may modulate T-cell response. In this sense, O’Garra
etal.[34]havereportedthatB1cellssecretelargeamountsof
IL-10 and, consequently, can contribute to the susceptibility
of BALB/c mice to L. major infection by skewing the T-
helper cell network towards a Th2 phenotype. In this way, it
has been observed that L. major infection of B-cell-defective
BALB/c Xid mice induces a less severe disease compared to
wild-type control mice [35]. Another report indicates that
the behavior of L. major-infected Xid mice can be explained
more in relation to the high endogenous IFN-gamma pro-
duction than to the lack of B1 cells. Indeed, B1-cell-deplet-
ed irradiated mice showed similar or even worse disease
progression compared to control BALB/c mice [36].
B1 cells would also be implicated in the pathogenesis of
toxoplasmosis through the production of Abs against the
heat shock protein 70 of T. gondii that also recognize mice
HSP70 [37]. These Abs seem to have a pathogenic role in
toxoplasmosis as their injection in T. gondii-infected mice
clearly increases the number of parasites in mice brain [38].
Moreover, IL-10 produced by B1 cells could, in turn, favor T.
gondii survival. Then, ﬁne tune regulation of the exacerbated4 Journal of Parasitology Research
Th1 response by IL-10 is important during T. gondii infec-
tion.
MZ B cells are also considered innate-like cells that can
be induced to diﬀerentiate into short-lived plasma cells in
the absence of BCR ligation. Splenic MZ B cells can be
distinguished from the other splenic B cells by CD24high,
IgMhigh,I g D high, CD23− expression, as well as by their higher
expression of CD21. It is known that these B cells mediate
humoral immune responses against blood-borne type 2 T-
independent antigens [39] but their role in parasite infection
has been scarcely studied. Induction of a T-independent
anti-trypanosome IgM response has been shown to be a
crucialfactorinT. brucei parasiteelimination [1]. Even when
increased splenic cellularity occurs after T. brucei infection,
a signiﬁcant reduction of splenic IgM+ MZ B-cell numbers
takes place right after the ﬁrst week of infection [40]. The
infection-associated disappearance of the MZ B cells from
the spleen could be explained by two independent mech-
anisms, namely, cell diﬀerentiation and/or cell death. Sup-
porting the ﬁrst possibility is the observation that the rapid
disappearance of MZ B cells coincided with the temporary
accumulation of IgM+ plasma cells. The analysis of MZ B
cells that remain in the spleen in the days following the clear-
ance of the ﬁrst peak of parasitemia revealed that these cells
upregulated Annexin V expression. In addition, these cells
exhibit caspase 3 gene expression as well as the conversion
of procaspase 3 into the cleaved 12kD and 17kD caspase 3
activation products suggesting the induction of trypanoso-
miasis-associated apoptosis in the splenic MZ B-cell popula-
tion [40]. As in African trypanosomes, P. chabaudi chabaudi
infection also caused a severe depletion of MZ B cells in
the spleen [41] and this loss is mainly the result of the
highly increased rate of apoptosis [24]. As MZ B cells serve
as an important source for T-cell independently generated
IgM+ plasma cells during early stages of infection, apoptosis
induction of MZ B cells can be used by parasites as strategy
to avoid early IgM protective response and, consequently,
prolong their survival.
5. ProtozoanInfectionsInduceMassive
B-CellResponsewithPolyclonalActivationof
SplenicB Cells
Whereas the BM of some protozoan-infected mice suﬀers
from a strong B-lineage-cell depletion, the spleens show a
marked cellular hyperplasia as a consequence of an intense
B-cell response. A detailed analysis of splenic B-cell response
was performed in experimental Chagas disease and malaria
[10,41].AnextrafollicularAbresponse,inmiceinfectedwith
T. cruzi, is evident a few days after infection and reached a
peak after 18 days of infection. This extended kinetics of the
extrafollicular response could be characteristic of infections
caused by blood circulating protozoan parasites since in P.
chabaudi chabaudi infection extrafollicular plasmablasts are
visible from day 4, and by day 10 they are unconventionally
sited in the periarteriolar region of the white pulp. In this
region, in both T. cruzi and Plasmodium infection, extrafol-
licular plasmablasts form clusters occupying part of the area
normally ﬁlled by T cells. The kinetics of the appearance of
GCs during T. cruzi and Plasmodium infection are similar to
those observed after immunization with classical haptenated
proteins, where GCs are visible within the 8 days of im-
munization [42]. In addition, we detected functional (Ab
producing) GCs in atypical sites. The GCs in the spleens of T.
cruzi-infected mice persisted for at least 32 days resembling
the kinetics of the response seen in P. chabaudi [41]a n dL.
amazonensis [43] infections. We observed that even though
T. cruzi infection induces early, persistent, and massive ex-
trafollicular and follicular plasmablast responses together
with classical and ectopic GCs, infected mice have a delayed
parasite-speciﬁc Ab response. A key ﬁnding of our study
[10] is that, while an important amount of Abs is rapidly
secreted during infection, antigen speciﬁc antibodies were
not detected until the third week of infection.
The consequence of the massive extrafollicular and fol-
licular B-cell response is the polyclonal B-cell activation that
leads to hypergammaglobulinemia with serum Abs speciﬁc
for the parasite and self- and/or nonrelated Ags [44–46].
In leishmaniasis, hypergammaglobulinemia was described in
both L. major-susceptible and -resistant mouse strains. T.
congolense infection also results in a strong production of
non-parasite-speciﬁcAbscharacterizedbythepredominance
of IgG2a- and IgG2b isotypes [47]. All the mouse strains
infected with T. congolense present a marked increase in
splenic B cells resulting in a nonspeciﬁc polyclonal activation
of lymphocytes that aﬀects primarily B cells. In strains of T.
congolensemicewhichsurvivedlongest,thatis,C57B1/6Jand
AKR/A, the increase in splenic B cells is less marked.
Diﬀerent roles are proposed for polyclonal B-cell activa-
tion, which can be crucial for early host defense by contrib-
uting with Abs speciﬁc for a spectrum of conserved struc-
tures present in the pathogens. Additionally, polyclonal
activation can be a mechanism triggered by microorganisms
to escape the host-speciﬁc immune response by diluting
pathogen-speciﬁc Abs while increasing irrelevant antibodies.
Accordingly, recently it has been reported that C57Bl/6 mice,
resistant to T. cruzi infection, had improved parasite-speciﬁc
humoral responses that were associated with decreased poly-
clonal B-cell activation. In the context of parasite infection,
Bryan et al. [48] study shows that Th2 cytokine responses
were associated with ampliﬁed polyclonal B-cell activation
and diminished speciﬁc humoral immunity. This report
demonstrate, that polyclonal B-cell activation during acute
experimental Chagas disease is not a generalized response
and suggests that the nature of humoral immunity during T.
cruzi infection contributes to host susceptibility. In leishma-
niasis visceral, at early times after infection, there is a marked
B-cell expansion in the draining lymph nodes of the site of
the infection, which persists throughout infection. As early
as day 7 after infection, polyclonal antibodies (TNP, OVA,
chromatin) were observed in infected mice and the levels
appearedcomparabletothespeciﬁcantileishmaniaresponse.
Although B-cell-deﬁcient JhD BALB/c mice are relatively
resistant to infection, neither B-cell-derived IL-10 nor B-cell
antigen presentation appears to be primarily responsible for
the elevated parasitemia. Interestingly, passive transfer andJournal of Parasitology Research 5
reconstitution of JhD BALB/c with secretory immunoglobu-
lins (IgM or IgG; speciﬁc or nonspeciﬁc immune complexes)
results in increased susceptibility to L. infantum infection
[49].
Another potential deleterious role for polyclonal activa-
tion is that it could potentially turn on anti-self-responses
and lead to autoimmune manifestations during chronic in-
fections. IgG autoantibodies to brain antigens are increased
in P. falciparum-infected patients and correlate with disease
severity in African children [50]. Autoreactive Abs against
endocardium and nerves can be detected in mice and hu-
mans infected with T. cruzi [51, 52] and are thought to be
responsible for much of the Chagas’ disease pathological
damage. Recently, we reported that BAFF-BAFF-R signaling
in T. cruzi infection partially controls polyclonal B-cell re-
sponse but not parasite-speciﬁc class-switched primary
eﬀectorsBcells.BAFF(TNFsuperfamilyBlymphocytestim-
ulator), a crucial factor for the survival of peripheral B
cells [53–55] associated to the development of autoimmune
disorders [56], is produced early and persists throughout
the infection with T. cruzi. By BAFF blockade we observed
that this cytokine mediates the mature B-cell response and
the production of non-parasite-speciﬁc IgM and IgG and
inﬂuences the development of antinuclear IgG [57].
In addition, polyclonal B-cell activation can be responsi-
ble for maintenance of memory B-cell responses because of
the continuous, unrestricted stimulation of memory B cells
whose Ab production may be sustained in the absence of the
antigens binding-speciﬁc BCR [58].
6. B CellsInﬂuence the Characteristicof
CellularImmuneResponse BecauseThey Act
asAPC andCytokine/Chemokine Producers
Besides being the precursors of the Ab-secreting cells, B cells
are committed to do other immune functions such as Ag
presentation to T cells or cytokine/chemokine production.
It has been widely studied that CD8+ CTL are important
for protective T. cruzi immunity [59, 60]b u tg e n e r a l l y
they are not induced by soluble protein vaccines. However,
a mechanism known as cross-priming has been described
whereby certain professional APC can induce CD8+ T-cell
responses after the uptake of exogenous Ag [61]. Hoft et al.
[62] have demonstrated that the APC functions of B cells
may be important for the induction of optimal vaccine-
induced responses in mice immunized with a mix of CpG
and T. cruzi transsialidase, an enzyme involved in parasite
infectivity. They also demonstrate that mice deﬁcient in B
cells (uMT mice) fails to induce protective immunity when
they were immunized with CpG and T. cruzi transsialidase.
This failure of uMT mice to be protected was associated
with the absence of T. cruzi transsialidase-speciﬁc CD8+ T
cell response, suggesting that B cells may be important for
the cross-priming of CD8+ CTL. In addition, it has been
reported that T. cruzi-infected B-cell-deﬁcient mice have
reduced numbers of CD8+ splenic T cells and impaired gen-
eration of central or eﬀector splenic memory T cells [63].
T. gondii-infected C57BL/6 mice develop a robust and
uncontrolled Th1 response, and it has been reported that
T. gondii-primed B cells, but not naive B cells, were able to
increase IFN gamma production by splenic T cells in vivo.
The mechanisms involved may be linked to the presence of
membrane-bound TNF on B-cell surface [64].
The ﬁne tune regulation of migratory cells during infec-
tion is an important event in which chemokines and their
receptors play a leading role. Diﬀerent reports have demon-
strated that the chemokine receptor CCR5 plays a role in
systemicprotectionandcardiacinﬂammationduringT.cruzi
infection [65, 66]. CCR5+ cells migrate to both mucosal and
systemicsitesinresponsetothechemokinesCCL3(MIP-1a),
CCL4 (MIP-1b), and CCL5 (RANTES). In line with these
reports, Sullivan et al. [67] showed that neutralization of
CCL5inCCR5−/− T.cruzi-immunemiceresultsindecreased
levels of T. cruzi-speciﬁc B cell responses and decreased
mucosal protection in these mice. They also showed that
CCL5 produced by B cells acts in an autocrine manner to
increase B cell proliferation and total IgM secretion.
7. Established Memory B CellResponse Is
Affectedby ProtozoanParasiteInfections
A hallmark of adaptive immunity is the ability to generate
humoral immunological memory by which memory B cells
could respond more rapidly and robustly to re-exposure
to a new infection. Interestingly, it has been reported that
T. brucei infection is capable of abrogating the eﬃcacy
of the vaccine-induced protective responses against non-
related pathogens such as B. pertussis [40]. In the same line,
Strickland and Sayles [68] showed that T. gondii infected
mice which were immunized with SRBC had a depression
not only in the primary, but also in the secondary humoral
immune response, since they showed less IgM and IgG
splenic Ab-secreting cells than non-infected control mice.
All the data discussed in the present review indicate that
protozoan parasites not only aﬀect the development of the
c ellsin v ol v edinA bpr oduction[69]butalsoaﬀectanalready
establishedhumoralresponseagainstotherpathogens.Then,
the identiﬁcation of mechanisms able to improve B cell re-
sponse and, consequently, parasite control will also be ben-
eﬁcial to avoid the deterioration of a memory response to
other pathogens.
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